Chiron Real Estate Inc. reported the three months ended December 31, 2022 results: revenue $36.3 million, net income $0.4 million, EPS $0.01 per diluted share.
“or $0.24 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 19.6% year-over-year to $36.3 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. Full Year 2022 Highlights · Net income attributable to common stockholders was”
Dr. Roscoe Moore, Jr. departed as director at Chiron Real Estate Inc..
“On January 19, 2023, Dr. Roscoe Moore, Jr. notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Board, effective as of the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”).”
Governance Changes
Chiron Real Estate Inc.: Board approved and adopted Fourth Amended and Restated Bylaws to ensure compliance with federal proxy rules, including Rule 14a-19, among other administrative amendments (effective 2022-12-07).
“Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. At a meeting of the Board of Directors (the “Board”) of Global Medical REIT Inc., a Maryland corporation (the “Company”), held on December 7, 2022, the Board approved and adopted effective as of such date the Fourth Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), amending certain provisions to ensure compliance with the federal proxy rules, including Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), among other administrative amendments.”
Earnings Releases
Chiron Real Estate Inc. reported nine months ended September 30, 2022 results: revenue $101.0 million, net income $13.0 million, EPS $0.20 per diluted share.
“Net income attributable to common stockholders was $13.0 million, or $0.20 per diluted share, as compared to $8.0 million, or $0.13 per diluted share, in the comparable prior year period. · FFO of $48.6 million, or $0.70 per share and unit, as compared to $42.6 million, or $0.67 per share and unit, in the comparable prior year period. · AFFO of $51.5 million, or $0.74 per share and unit, as compared to $45.0 million, or $0.71 per share and unit, in the comparable prior year period. · Increased total revenue 18.0% year-over-year to $101.0 million, primarily driven by the Company’s acquisition activity.”
Earnings Releases
Chiron Real Estate Inc. reported three months ended September 30, 2022 results: revenue $35.4 million, net income $8.1 million, EPS $0.12 per diluted share.
“Net income attributable to common stockholders was $8.1 million, or $0.12 per diluted share, as compared to $3.7 million, or $0.06 per diluted share, in the comparable prior year period. · Funds from Operations (“FFO”) of $16.2 million, or $0.23 per share and unit, as compared to $15.8 million, or $0.23 per share and unit, in the comparable prior year period. · Adjusted Funds from Operations (“AFFO”) of $17.1 million, or $0.25 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 18.1% year-over-year to $35.4 million, primarily driven by the Company’s acquisition activity.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.